PACB 8-K 2026-06-04

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) 8-K dated 2026-06-04 — accession 0001299130-26-000092. This URL is the filing, not the PACB hub.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) is a medical devices company listed on US.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. filed a 8-K on 2026-06-04. Accession 0001299130-26-000092.

Cached items: 5.02, 5.07, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported PACB revenue for 2025-12-31 was $160.0M. Net income was -$546.4M. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. PACB currently screens at market cap $387.1M.

Not investment advice. The PACB SEC hub lists recent forms. The stock page is the research view.